Comment on: Bisphosphonates and osteonecrosis of the jaw [10]

Rheumatology

Volumn 47, Issue 3, 2008, Pages 383-

  Bianchi, M L ^a   Limonta, C ^a   Frasunkiewicz, J ^b   Biggioggero, M ^a   Vai, S ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CHLORHEXIDINE; ERYTHROMYCIN; GLUCOCORTICOID; PAMIDRONIC ACID; PENICILLIN G;

ADOLESCENT DISEASE; BONE NECROSIS; CHILDHOOD DISEASE; DENTAL CARE; DENTAL CARIES; FIBROUS DYSPLASIA; FRACTURE; HUMAN; JAW DISEASE; LETTER; MOUTH EXAMINATION; MULTIPLE CYCLE TREATMENT; OSTEOGENESIS IMPERFECTA; PREVENTIVE DENTISTRY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SECONDARY OSTEOPOROSIS; TOOTH EXTRACTION; TOOTH MALFORMATION; TREATMENT DURATION;

EID: 39449097585     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem387     Document Type: Letter

References (5)

1. Shenker NG, Jawad ASM. Bisphosphonates and osteonecrosis of the jaw. Rheumatology 2007;46:1049-51.
2. Marx RE. Pamidronate (Aredia) and zolendronate (Zometa) induced avascular necrosis of the jaws: A growing opidemic. J Oral Maxillofac Surg 2003;61:1115-8.
3. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaw associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34.
4. Ficarra G, Beninati F. Bisphosphonate-related osteonecrosis of the jaws: the point of view of the oral pathologist Clin Cases Min Boris Metabol 2007;4:53-7.
5. Bagan JV, Jimenez Y, Murillo J et al. Jaw osteonecrosis associated with bisphosphonates: Multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 2006;42:327-9.